Kuros Biosciences AG (CSBTF)
OTCMKTS · Delayed Price · Currency is USD
32.00
+0.09 (0.27%)
Feb 11, 2026, 9:35 AM EST

Kuros Biosciences AG Statistics

Total Valuation

CSBTF has a market cap or net worth of 1.27 billion. The enterprise value is 1.25 billion.

Market Cap1.27B
Enterprise Value 1.25B

Important Dates

The next estimated earnings date is Tuesday, March 10, 2026.

Earnings Date Mar 10, 2026
Ex-Dividend Date n/a

Share Statistics

Current Share Class 39.18M
Shares Outstanding n/a
Shares Change (YoY) +36.07%
Shares Change (QoQ) n/a
Owned by Insiders (%) 26.27%
Owned by Institutions (%) 17.06%
Float 28.89M

Valuation Ratios

PE Ratio n/a
Forward PE 87.51
PS Ratio 9.80
PB Ratio 13.21
P/TBV Ratio 29.07
P/FCF Ratio n/a
P/OCF Ratio 1,235.07
PEG Ratio n/a
Financial Ratio History

Enterprise Valuation

The stock's EV/EBITDA ratio is 148.40, with an EV/FCF ratio of -1,477.06.

EV / Earnings -164.09
EV / Sales 9.32
EV / EBITDA 148.40
EV / EBIT 249.74
EV / FCF -1,477.06

Financial Position

The company has a current ratio of 2.25, with a Debt / Equity ratio of 0.02.

Current Ratio 2.25
Quick Ratio 1.68
Debt / Equity 0.02
Debt / EBITDA 0.28
Debt / FCF -2.66
Interest Coverage 0.72

Financial Efficiency

Return on equity (ROE) is -8.62% and return on invested capital (ROIC) is 3.43%.

Return on Equity (ROE) -8.62%
Return on Assets (ROA) 2.57%
Return on Invested Capital (ROIC) 3.43%
Return on Capital Employed (ROCE) 4.65%
Weighted Average Cost of Capital (WACC) 8.06%
Revenue Per Employee 822,503
Profits Per Employee -48,283
Employee Count158
Asset Turnover 1.10
Inventory Turnover 1.14

Taxes

In the past 12 months, CSBTF has paid 1.35 million in taxes.

Income Tax 1.35M
Effective Tax Rate n/a

Stock Price Statistics

The stock price has increased by +38.53% in the last 52 weeks. The beta is 0.62, so CSBTF's price volatility has been lower than the market average.

Beta (5Y) 0.62
52-Week Price Change +38.53%
50-Day Moving Average 34.99
200-Day Moving Average 22.32
Relative Strength Index (RSI) 41.61
Average Volume (20 Days) 651

Short Selling Information

Short Interest n/a
Short Previous Month n/a
Short % of Shares Out n/a
Short % of Float n/a
Short Ratio (days to cover) n/a

Income Statement

In the last 12 months, CSBTF had revenue of 129.96 million and -7.63 million in losses. Loss per share was -0.17.

Revenue129.96M
Gross Profit 115.28M
Operating Income 4.85M
Pretax Income -6.06M
Net Income -7.63M
EBITDA 7.32M
EBIT 4.85M
Loss Per Share -0.17
Full Income Statement

Balance Sheet

The company has 23.19 million in cash and 2.25 million in debt, with a net cash position of 20.94 million.

Cash & Cash Equivalents 23.19M
Total Debt 2.25M
Net Cash 20.94M
Net Cash Per Share n/a
Equity (Book Value) 96.38M
Book Value Per Share 2.39
Working Capital 42.45M
Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was 1.03 million and capital expenditures -1.88 million, giving a free cash flow of -847,501.

Operating Cash Flow 1.03M
Capital Expenditures -1.88M
Free Cash Flow -847,501
FCF Per Share n/a
Full Cash Flow Statement

Margins

Gross margin is 88.70%, with operating and profit margins of 3.73% and -5.87%.

Gross Margin 88.70%
Operating Margin 3.73%
Pretax Margin -4.66%
Profit Margin -5.87%
EBITDA Margin 5.64%
EBIT Margin 3.73%
FCF Margin n/a

Dividends & Yields

CSBTF does not appear to pay any dividends at this time.

Dividend Per Share n/a
Dividend Yield n/a
Dividend Growth (YoY) n/a
Years of Dividend Growth n/a
Payout Ratio n/a
Buyback Yield -36.07%
Shareholder Yield -36.07%
Earnings Yield -0.60%
FCF Yield -0.07%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value n/a
Lynch Upside n/a
Graham Number n/a
Graham Upside n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date n/a
Split Type n/a
Split Ratio n/a

Scores

CSBTF has an Altman Z-Score of 14.95 and a Piotroski F-Score of 5.

Altman Z-Score 14.95
Piotroski F-Score 5